With the overall aim of establishing an overarching national pharmaceutical framework to help guide policy reform this report has 3-key objectives: 1) To undertake a mapping of the key trends and ...

Groups covering the pharma, biotech and generics industries have come together to raise their concerns about the growing cost of monitoring drug safety in Europe. A total of five associations ...

Christoph Krähenbühl reviews the final draft Delegated Act (DA) and summarises the key actions for pharma companies. The final draft of the EU-Falsified Medicines Directive 'Safety Features ...

Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy ... Relative safety and efficacy could only be assessed ...

The Master’s Programme in Pharmaceutical Research, Development and Safety offers the opportunity to obtain a comprehensive overview of the life cycle of drugs and their use. The study program combines ...

As technology advances and regulatory scrutiny intensifies, it is critical to ensure the safety and authenticity of ...

Students acquire in- depth knowledge in various fields of Pharmaceutical Sciences and gain scientific skills and insight into drug development prozess. Compulsory subjects, electives and a research ...

This course is available as an outside option to students on other programmes where regulations permit. The aim of this course is to introduce students to the economics of pharmaceutical markets and ...

如果您想了解有关原子能机构工作的更多信息，请注册获取我们的每月动态，其中包含我们最重要的新闻、多媒体和其他信息。 电子信箱地址 * 国际原子能机构科学和技术出版物可以通过多种参数进行检索：出版年份、主题和类型。使用搜索框输入搜索条件，或使用文本字段按标题、关键字、ISBN、ISSN或序列号进行搜索。 按标题、ISBN、ISSN、序列号搜索 ...

To address this problem, Lantern Pharma is reinventing the cancer drug ... clinical efficacy, and safety. The second stage consists of lab genomic analysis of patient samples and genetic models.

Many promising preclinical and clinical trial programs are terminated for reasons unrelated to science, drug efficacy, or safety. Each year, the pharmaceutical industry terminates hundreds ...

The Master ́s Programme in Pharmaceutical Research, Development and Safety takes two years of full-time studies to complete. The academic activities conducted based on a personal study plan sum 120 ...